These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 24885022)

  • 1. Estrogen receptor α and aryl hydrocarbon receptor independent growth inhibitory effects of aminoflavone in breast cancer cells.
    Brinkman AM; Wu J; Ersland K; Xu W
    BMC Cancer; 2014 May; 14():344. PubMed ID: 24885022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aryl hydrocarbon receptor activation of an antitumor aminoflavone: basis of selective toxicity for MCF-7 breast tumor cells.
    Loaiza-Pérez AI; Kenney S; Boswell J; Hollingshead M; Alley MC; Hose C; Ciolino HP; Yeh GC; Trepel JB; Vistica DT; Sausville EA
    Mol Cancer Ther; 2004 Jun; 3(6):715-25. PubMed ID: 15210858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
    Al-Dhfyan A; Alhoshani A; Korashy HM
    Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of aryl hydrocarbon receptor-dependent transcription by resveratrol or kaempferol is independent of estrogen receptor α expression in human breast cancer cells.
    Macpherson L; Matthews J
    Cancer Lett; 2010 Dec; 299(2):119-29. PubMed ID: 20846786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aryl hydrocarbon receptor activation by aminoflavone: new molecular target for renal cancer treatment.
    Callero MA; Suárez GV; Luzzani G; Itkin B; Nguyen B; Loaiza-Perez AI
    Int J Oncol; 2012 Jul; 41(1):125-34. PubMed ID: 22485252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reactivation of estrogen receptor α by vorinostat sensitizes mesenchymal-like triple-negative breast cancer to aminoflavone, a ligand of the aryl hydrocarbon receptor.
    Stark K; Burger A; Wu J; Shelton P; Polin L; Li J
    PLoS One; 2013; 8(9):e74525. PubMed ID: 24058584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AhR ligand Aminoflavone inhibits α6-integrin expression and breast cancer sphere-initiating capacity.
    Brantley E; Callero MA; Berardi DE; Campbell P; Rowland L; Zylstra D; Amis L; Yee M; Simian M; Todaro L; Loaiza-Perez AI; Soto U
    Cancer Lett; 2016 Jun; 376(1):53-61. PubMed ID: 26996297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AHR and GPER mediate the stimulatory effects induced by 3-methylcholanthrene in breast cancer cells and cancer-associated fibroblasts (CAFs).
    Cirillo F; Lappano R; Bruno L; Rizzuti B; Grande F; Guzzi R; Briguori S; Miglietta AM; Nakajima M; Di Martino MT; Maggiolini M
    J Exp Clin Cancer Res; 2019 Aug; 38(1):335. PubMed ID: 31370872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aminoflavone induces oxidative DNA damage and reactive oxidative species-mediated apoptosis in breast cancer cells.
    McLean L; Soto U; Agama K; Francis J; Jimenez R; Pommier Y; Sowers L; Brantley E
    Int J Cancer; 2008 Apr; 122(7):1665-74. PubMed ID: 18059023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indole-3-carbinol and its N-alkoxy derivatives preferentially target ERα-positive breast cancer cells.
    Caruso JA; Campana R; Wei C; Su CH; Hanks AM; Bornmann WG; Keyomarsi K
    Cell Cycle; 2014; 13(16):2587-99. PubMed ID: 25486199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aminoflavone, a ligand of the aryl hydrocarbon receptor, inhibits HIF-1alpha expression in an AhR-independent fashion.
    Terzuoli E; Puppo M; Rapisarda A; Uranchimeg B; Cao L; Burger AM; Ziche M; Melillo G
    Cancer Res; 2010 Sep; 70(17):6837-48. PubMed ID: 20736373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benzyl butyl phthalate induces necrosis by AhR mediation of CYP1B1 expression in human granulosa cells.
    Chen HS; Chiang PH; Wang YC; Kao MC; Shieh TH; Tsai CF; Tsai EM
    Reprod Toxicol; 2012 Jan; 33(1):67-75. PubMed ID: 22138065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel naphthalimide that selectively targets breast cancer via the arylhydrocarbon receptor pathway.
    Gilbert J; De Iuliis GN; McCluskey A; Sakoff JA
    Sci Rep; 2020 Aug; 10(1):13978. PubMed ID: 32814815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen receptor-α and aryl hydrocarbon receptor involvement in the actions of botanical estrogens in target cells.
    Gong P; Madak-Erdogan Z; Flaws JA; Shapiro DJ; Katzenellenbogen JA; Katzenellenbogen BS
    Mol Cell Endocrinol; 2016 Dec; 437():190-200. PubMed ID: 27543265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel prenylflavone restricts breast cancer cell growth through AhR-mediated destabilization of ERα protein.
    Tiong CT; Chen C; Zhang SJ; Li J; Soshilov A; Denison MS; Lee LS; Tam VH; Wong SP; Xu HE; Yong EL
    Carcinogenesis; 2012 May; 33(5):1089-97. PubMed ID: 22345291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of CYP1A1 and CYP1B1 in human breast epithelial cells and breast tumor cells.
    Spink DC; Spink BC; Cao JQ; DePasquale JA; Pentecost BT; Fasco MJ; Li Y; Sutter TR
    Carcinogenesis; 1998 Feb; 19(2):291-8. PubMed ID: 9498279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen receptor subtype- and promoter-specific modulation of aryl hydrocarbon receptor-dependent transcription.
    Wihlén B; Ahmed S; Inzunza J; Matthews J
    Mol Cancer Res; 2009 Jun; 7(6):977-86. PubMed ID: 19470599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aryl Hydrocarbon Receptor-Dependent Metabolism Plays a Significant Role in Estrogen-Like Effects of Polycyclic Aromatic Hydrocarbons on Cell Proliferation.
    Hýžd'alová M; Pivnicka J; Zapletal O; Vázquez-Gómez G; Matthews J; Neca J; Pencíková K; Machala M; Vondrácek J
    Toxicol Sci; 2018 Oct; 165(2):447-461. PubMed ID: 30137621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 12-O-tetradecanoylphorbol-13-acetate upregulates the Ah receptor and differentially alters CYP1B1 and CYP1A1 expression in MCF-7 breast cancer cells.
    Spink BC; Fasco MJ; Gierthy JF; Spink DC
    J Cell Biochem; 1998 Sep; 70(3):289-96. PubMed ID: 9706865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Constitutive expression of AhR and BRCA-1 promoter CpG hypermethylation as biomarkers of ERα-negative breast tumorigenesis.
    Romagnolo DF; Papoutsis AJ; Laukaitis C; Selmin OI
    BMC Cancer; 2015 Dec; 15():1026. PubMed ID: 26715507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.